GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acasti Pharma Inc (TSXV:ACST) » Definitions » Short Interest

Acasti Pharma (TSXV:ACST) Short Interest


View and export this data going back to 2011. Start your Free Trial

What is Acasti Pharma Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Acasti Pharma's Short Interest

For the Biotechnology subindustry, Acasti Pharma's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acasti Pharma's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acasti Pharma's Short Interest distribution charts can be found below:

* The bar in red indicates where Acasti Pharma's Short Interest falls into.



Acasti Pharma (TSXV:ACST) Business Description

Traded in Other Exchanges
Address
3009 Boulevard de la Concorde East, Suite 102, Laval, QC, CAN, H7E 2B5
Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.

Acasti Pharma (TSXV:ACST) Headlines

From GuruFocus

Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule

By Stock market mentor Stock market mentor 01-25-2023

Acasti Pharma Inc. Announces the Resignation of a Director

By PRNewswire PRNewswire 03-30-2023